[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.129.96. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 640
Citations 0
From the JAMA Network
July 2016

Subcutaneous Dupilumab and Mometasone Furoate Nasal Spray for Chronic Rhinosinusitis With Polyps

Author Affiliations
  • 1Department of Otolaryngology, Washington University in St Louis, St Louis, Missouri
JAMA Otolaryngol Head Neck Surg. 2016;142(7):698-699. doi:10.1001/jamaoto.2016.0678

Chronic rhinosinusitis with polyps (CRSwP) remains a challenging condition to treat. Patients vary substantially in their responses to existing therapies. Some patients require surgery with minimal postoperative medical management, while others require more extensive medical therapy with long-term use of topical and short-course “rescue” oral steroids. Some patients have refractory disease despite aggressive surgical and medical therapies. A recent systematic review1 of the best evidence regarding medical treatments for CRSwP identified only topical steroids, saline irrigations, and systemic steroids as having American Heart Association A-I level evidence. These medications, however, have no specific targets in the inflammatory pathways of CRSwP.

First Page Preview View Large
First page PDF preview
First page PDF preview
×